The global bio decontamination market is highly diversified, with products ranging from equipment, services, and consumable & accessories. Bio decontamination helps eliminate harmful microorganisms, spores, viruses, bacterial toxins from non-porous surfaces of healthcare facilities as well as pharmaceutical and biotechnology cleanrooms which require sterilization. Hydrogen peroxide gas (HPG) bio decontamination technology is gaining popularity due to its effectiveness and environment-friendly nature. HPG systems utilize hydrogen peroxide vapor or gas plasma for decontaminating healthcare facilities and industrial equipment in a less resource-intensive manner. The growing prevalence of hospital-acquired infections and stringent regulatory guidelines have propelled the demand for bio decontamination services and equipment in recent years.
The Global bio decontamination market is estimated to be valued at US$ 268.5 Mn in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the bio decontamination market are STERIS Corporation, Ecolab, Inc., TOMI Environmental Solutions, Inc., JCE Biotechnology, Fedegari Autoclavi SpA, Howorth Air Technology Ltd., Noxilizer, Inc., ClorDiSys Solutions, Inc., Wales Group, and Wenzhou Weike Biological Laboratory Equipment Co., Ltd.
The key opportunities in the market include increasing outsourcing of bio decontamination services by healthcare facilities and focus on preventive deterrence against hospital-acquired infections. Advancements in Vaporized Hydrogen Peroxide sterilization technology have augmented its use for decontaminating isolation rooms and operating rooms between surgeries.
Market Drivers
The increasing incidence of hospital-acquired infections is a key growth driver for the bio decontamination market. As per the estimates of WHO, over 5% of hospitalized patients in developed nations and over 10% in developing nations acquire infections during their hospital stay. This has strengthened the focus on infection control and prevention of transmission of harmful pathogens via medical equipment, surfaces, and facilities. Stringent regulatory mandates regarding decontamination of healthcare premises by regulatory bodies such as FDA and EPA are also propelling the demand for bio decontamination services and technologies.
Current challenges in the Bio Decontamination Market:
The bio decontamination market is experiencing challenges such as the high cost of bio decontamination services, stringent regulatory guidelines, and concerns regarding the toxicity of chemicals used for decontamination. The development of new and advanced decontamination technologies also requires significant investments which add to the overall cost. Additionally, obtaining regulatory approvals for bio decontamination technologies and services is a lengthy and complex process. The toxicity of chemicals used during the decontamination process also raises safety concerns. Protecting workers and ensuring environmental safety adds further complexity and compliance requirements.
SWOT Analysis
Strength: Advanced technologies for effective decontamination, proven record to control spread of infections
Weakness: High overall costs, regulatory compliance is complex and time-taking
Opportunity: Growing need for infection control in industries like pharmaceuticals and healthcare, development of green decontamination methods
Threats: Stringent regulations can delay approvals, economic slowdowns impact capital investments
Geographical Regions with high market concentration:
North America currently dominates the global bio decontamination market, both in terms of value and volume. This is due to robust healthcare infrastructure, high healthcare spending, stringent regulations, and presence of major market players in the region. Europe is another major revenue generator owing torising hospital-acquired infections and implementation of various regulatory guidelinesregarding sterilization and disinfection practices.
Fastest growing region:
The bio decontamination market in Asia Pacific is expected to grow at the fastest rate during the forecast period. This can be attributed to factors such as growing medical tourism, increasing healthcare infrastructure development, rising incidence of infections, and growing awareness about decontamination. China, India and other Asian countries are expected to offer lucrative opportunities for market players in the coming years.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it